Patent Number | Title | Applicant | Opposition Date |
---|---|---|---|
EP3464373 | Use Of Anti-Pd-1 Antibody In The Treatment Of Patients With Colorectal Cancer | BRISTOL-MYERS SQUIBB COMPANY | Jul 26, 2022 |
EP3060582 | Assays For Determining Plasma Kallikrein System Biomarkers | DYAX CORP. | Jun 23, 2021 |
EP3017050 | Two-Phase Fermentation Process For The Production Of An Organic Compound | ISOBIONICS B.V. | Jun 4, 2021 |
EP2992891 | Pharmaceutical Composition Comprising Brivaracetam And Lacosamide With Synergistic Anticonvulsant Effect | UCB PHARMA GMBH | May 3, 2021 |
EP2978419 | Compositions For Improving Cell Viability And Methods Of Use Thereof | AMYLYX PHARMACEUTICALS INC. | Jan 12, 2021 |
EP3043797 | Treating Infections With Ceftolozane/Tazobactam In Subjects Having Impaired Renal Function | MERCK SHARP & DOHME CORP. | Dec 21, 2020 |
EP2957552 | Vilanterol Formulations | ARVEN ILAC SANAYI VE TICARET A.S. | Oct 20, 2020 |
EP2957551 | Dry Powder Formulations Comprising Vilanterol | ARVEN ILAC SANAYI VE TICARET A.S. | Oct 13, 2020 |
EP1856051 | Amorphous Lercanidipine Hydrochloride | RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.P.A. | Jul 8, 2020 |
EP3300724 | Particle Containing At Least A Volatile Substance And Process For Its Preparation | ERBER AKTIENGESELLSCHAFT | Jun 2, 2020 |
Feel free to send us a message here and we will get back to you